Aaron Vernon: Designing scalable cell therapy manufacturing from day one (part 2)

About this episode

Aaron Vernon discusses scalable cell therapy manufacturing systems and strategies to improve efficiency.

In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes back Aaron Vernon, Chief Manufacturing Officer at Quell Therapeutics, for the second part of the discussion on building robust and scalable cell therapy manufacturing systems. Together, they explore how applying principles like the Theory of Constraints, designing smarter facility layouts, and implementing digital systems can reduce bottlenecks and improve throughput. Aaron brings over 20 years of experience leading manufacturing, engineering and supply chain operations across biologics and cell therapy. We’re grateful for his insights as the industry works to deliver more consistent, cost-effective therapies to patients at scale. Learn more: https://www.linkedin.com/in/aaronvernon/

People in this episode

Host: Jason C. Foster

Guest: Aaron Vernon

Topics covered

• cell therapy
• manufacturing
• scalability
• digital systems
• Theory of Constraints

Keywords

• cell therapy
• manufacturing systems
• throughput
• bottlenecks
• digital systems
• biologics

Mentioned in this episode

Organizations: Quell Therapeutics

More episodes of Ori Spotlight

• Ken Harris: Why AI and automation are CGT’s next inflection point · January 27, 2026 · 1h 3m
• Joe DePinto: Why advanced therapies need a new delivery model · January 13, 2026 · 1h 5m
• Jonathan Gluck: A personal account of navigating myeloma and CAR-T therapy · December 16, 2025 · 56 min
• John Khoury: The CGT developers who adapt new manufacturing techniques early will lead later · December 3, 2025 · 50 min
• Warner Biddle: Building a commercial model for CAR-T in autoimmune care · September 2, 2025 · 41 min
• Lavakumar Karyampudi: Building early-phase CGT infrastructure for translational success · August 12, 2025 · 1h 0m